Acord Clinical Research Workshop
ACORD 2014 took place on 7-13 September 2014
Sunshine Coast, Queensland, Australia
The ACORD 2014 report is currently pending
ESMO is pleased to continue its support of the ACORD Workshop, and for ESMO Faculty to join with other world renowned experts to provide oncology and allied health professionals with hands-on collaboration and guidance
Health professionals with training in medical, radiation, surgical and psycho-oncology, and/or palliative care, pharmacology and allied health disciplines.
- Imparting principles of good clinical trial design which yield clear results to apply both in the clinic and in future research projects and
- Exposing participants to the full spectrum of challenges in clinical research, from conventional anti neoplastic agents and multidisciplinary treatment regimens to biological therapy.
- A variety of educational components to aid in successful protocol design
- Development sessions where participants present and discuss their clinical trial proposal in detail
- Extensive session topics including areas such as global cancer research, principles of clinical trials design, phase I-III trials, basic biostatistics, epidemiology, meta-analysis and systematic review
2012 ACORD Workshop Report
Applications for ACORD are currently closed and will open again in November 2015. For more info please visit www.acord.org.au
Up to sixty participants are selected through a competitive application process. With an international focus, past Workshop participants have come from India, Nepal, Malaysia, China, Thailand, Singapore, Japan, Taiwan, Iran, Bangladesh, Philippines, Pakistan, Korea, United Kingdom, United States of America, Australia and New Zealand.
Fellowships overing fees, travel expenses, accommodation and meals are available to successful applicants.
Marc Buyse, Belgium, founder of the International Drug Development Institute
For a list of the previous 2010 ACORD Workshop faculty, please click here
In addition to the organizations below, the programme is also supported by a number of key Australian professional organisations including, the Haematology Society of Australia and New Zealand and the Australian Faculty of Radiation Oncology.